Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      FDA staff raises safety concerns over Trevena opioid drug

      FDA staff raises safety concerns over Trevena opioid drug

      Medical Dialogues Bureau12 Oct 2018 9:15 AM IST
      London: Staff reviewers of the U.S. Food and Drug Administration has recently raised safety concerns over Trevena Inc's opioid injection to treat...
      Kerala Ayurveda signs Joint Venture pact with Sanghvi Brands

      Kerala Ayurveda signs Joint Venture pact with Sanghvi Brands

      Medical Dialogues Bureau12 Oct 2018 9:15 AM IST
      New Delhi: Ayurvedic firm Kerala Ayurveda announced that it has entered into a joint venture pact with Sanghvi Brands to develop Ayurvedagram wellness...
      AcelRx shares surge after FDA staff says opioid safe

      AcelRx shares surge after FDA staff says opioid safe

      Medical Dialogues Bureau11 Oct 2018 4:38 PM IST
      With opioid abuse reaching epidemic proportions in the United States, the FDA has been extremely cautious about issuing new approvals and is looking...
      Indian medical device firms be given faster access to US-FDA: ASSOCHAM

      Indian medical device firms be given faster access to US-FDA: ASSOCHAM

      Medical Dialogues Bureau11 Oct 2018 4:10 PM IST
      New Delhi: The ASSOCHAM has suggested that the Indian firms engaged in the manufacture of medical devices, be enabled faster access to the US drug and...
      Merck Foundation plans to conduct 5th edition of Merck Africa Asia Luminary in Senegal

      Merck Foundation plans to conduct 5th edition of Merck Africa Asia Luminary in Senegal

      Medical Dialogues Bureau11 Oct 2018 10:08 AM IST
      Mumbai: Merck Foundation plans to conduct 5th edition of Merck Africa Asia Luminary in Senegal, the philanthropic arm of Merck KGaA Germany plans to...
      CVS, Aetna win U.S. approval for $69 billion deal

      CVS, Aetna win U.S. approval for $69 billion deal

      Medical Dialogues Bureau11 Oct 2018 9:20 AM IST
      WASHINGTON/NEW YORK: Pharmacy chain CVS Health Corpwon U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the...
      U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug

      U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug

      Medical Dialogues Bureau11 Oct 2018 9:15 AM IST
      Switzerland-based Roche, the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition...
      UK clinical trials fall as Brexit clouds drug approval process

      UK clinical trials fall as Brexit clouds drug approval process

      Medical Dialogues Bureau11 Oct 2018 9:00 AM IST
      LONDON: The number of new clinical trials started in Britain last year was 25 per cent lower than the average for 2009-16, as anxiety about Brexit's...
      Ceiling price of Phenytoin: DOP rejects application of Abbott Healthcare

      Ceiling price of Phenytoin: DOP rejects application of Abbott Healthcare

      Medical Dialogues Bureau10 Oct 2018 6:04 PM IST
      Department of Pharmaceutical has rejected the Abbott Healthcare review order for fixing the retail price of Phenytoin – 30 mg/5ml, cannot be accepted...
      Abraajs stake in 1 Billion Dollar healthcare fund to be split among other investors

      Abraajs stake in 1 Billion Dollar healthcare fund to be split among other investors

      Medical Dialogues Bureau10 Oct 2018 6:04 PM IST
      Lenders, which had been expecting AlixPartners to sell Abraaj’s stake in the fund to other partners or dilute the stake, view the move as the worst...
      China approves 17 anti-cancer drugs for medical insurance coverage

      China approves 17 anti-cancer drugs for medical insurance coverage

      Medical Dialogues Bureau10 Oct 2018 10:19 AM IST
      SHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said, part of its efforts to...
      Apollo Munich Health Insurance launches Cancer Plan

      Apollo Munich Health Insurance launches Cancer Plan 'iCan'

      Medical Dialogues Bureau10 Oct 2018 10:00 AM IST
      Hyderabad: Apollo Munich Health Insurance, a private health insurer, has recently launched a comprehensive Cancer plan known as 'iCan'.The salient...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok